Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients (Q35116211)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients
scientific article

    Statements

    Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients (English)
    Michael A Morse
    Robert Chapman
    John Powderly
    Kimberly Blackwell
    Tibor Keler
    Jennifer Green
    Renee Riggs
    Venky Ramakrishna
    Laura Vitale
    Biwei Zhao
    Stephen A Butler
    Amy Hobeika
    Takuya Osada
    Thomas Davis
    Timothy Clay
    H Kim Lyerly
    4844-4853

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit